PND12 COST-EFFECTIVENESS OF RASAGILINE VERSUS ROPINIROLE EXTENDED RELEASE IN DELAYING LEVODOPA IN THE TREATMENT OF EARLY PARKINSONS DISEASE IN THE UNITED STATES
Abstract
Authors
R Farkouh MR Wilson ML Tarrants J Castelli-Haley C Armand